Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Human papillomavirus DNA in cervical carcinoma—correlation with clinical data and influence on prognosis
- H. Ikenberg, W. Sauerbrei, U. Schottmüller, C. Spitz, A. Pfleiderer
- Medicine
- International journal of cancer
- 1 November 1994
Human papillomavirus (HPV) is a main factor in cervical carcinogenesis. However, data on the correlation of HPV with clinical features and the prognosis of cervical carcinoma remain controversial.… Expand
Occurrence of epidermal growth factor receptors in human adnexal tumors and their prognostic value in advanced ovarian carcinomas.
- T. Bauknecht, M. Runge, M. Schwall, A. Pfleiderer
- Medicine
- Gynecologic oncology
- 1 February 1988
Ninety-eight different malignant adnexal tumors were analyzed for the presence of epidermal growth factor (EGF)-specific binding sites and binding parameters were calculated by Scatchard plot… Expand
Prognosis of the adenocarcinoma of the cervix uteri: a comparative study.
- W. Kleine, K. Rau, D. Schwoeorer, A. Pfleiderer
- Medicine
- Gynecologic oncology
- 1 November 1989
The different prognoses for patients with adenocarcinomas and squamous cell carcinomas of the cervix uteri were proved by matched-pair analysis. One hundred forty-four patients with adenocarcinoma… Expand
Course, patterns, and risk-factors for chemotherapy-induced emesis in cisplatin-pretreated patients: a study with ondansetron.
- A. Du Bois, H. G. Meerpohl, W. Vach, F. Kommoss, E. Fenzl, A. Pfleiderer
- Medicine
- European journal of cancer
- 1 February 1992
Vomiting and nausea are the most distressing side-effects of cancer chemotherapy. With standard antiemetic regimens (e.g. metoclopramide based combinations) sufficient antiemetic control is achieved… Expand
Prognosis of the adenocarcinoma of the cervix uteri: A comparative study
- W. Kleine, K. Rau, D. Schwoeorer, A. Pfleiderer
- Medicine
- 1 May 1990
Use of serum squamous cell carcinoma antigen assays in chemotherapy treatment of cervical cancer Ngan HYS; Wong LC; Chan SYW; Ma HK Department of Obstetrics and Gynaecology, University of Hong Kong,… Expand
Doppler measurement of breast vascularity in women under pharmacologic treatment of benign breast disease.
- H. Madjar, M. Vetter, H. Proempeler, M. Breckwoldt, A. Pfleiderer
- Medicine
- The Journal of reproductive medicine
- 1 December 1993
Breast vascularization was measured with an 8-MHz continuous wave Doppler pencil probe. Flow values were low in asymptomatic women and high in patients with severe pain or dysplastic changes. Mild… Expand
Growth patterns and hormonal sensitivity of primary tumor, abdominal metastasis and ascitic fluid from human epithelial ovarian carcinomas in the tumor colony-forming assay.
- H. Runge, H. A. Neumann, T. Bauknecht, A. Pfleiderer
- Medicine
- European journal of cancer & clinical oncology
- 1 June 1986
The human tumor colony forming assay was used to evaluate the response of ovarian carcinoma cells from primary tumors, ascitic fluids and metastasis to hormonal treatment. In 12/35 patients a… Expand
Destruction of human solid tumors by alkyl lysophospholipids.
- M. Runge, R. Andreesen, A. Pfleiderer, P. G. Munder
- Biology, Medicine
- Journal of the National Cancer Institute
- 1 June 1980
Alkyl lysophospholipids (ALP) are synthetic analogs of the naturally occurring 2-lysophosphatidylcholine. The effect of ALP on the proliferation of 22 different gynecologic malignant tumors in humans… Expand
Microsatellite instability in ovarian neoplasms.
- B. L. King, M. Carcangiu, +4 authors B. Kacinski
- Biology, Medicine
- British Journal of Cancer
- 1 August 1995
Microsatellite instability has been observed in a variety of sporadic malignancies, but its existence in sporadic ovarian cancer has been the subject of conflicting reports. We have performed a… Expand
Steroidhormon-Rezeptoren beim Ovarialkarzinom und ihre klinische Bedeutung
- H. Geyer, G. Teufel, G. Gregorio, A. Pfleiderer
- Medicine
- 1 May 1984
Bei insgesamt 197 malignen Ovarialtumoren wurden Ostrogenrezeptoren (ER) und Progesteronrezeptoren (PR) bestimmt. In epithelialen Ovarialkarzinomen war die Haufigkeit der Rezeptoren wie in Mammakarzin